Custom Search
News
Tuesday 31 July 2007
Recordati signs deal with Meda to sell hypertensive drug in Spain
Recordati SpA, the Italian pharmaceutical company, said it has signed a long-term agreement with Meda to market a new antihypertensive drug in Spain.
Meda, which is based in Sweden, already has marketing rights for the drug in Germany and Scandinavia.
The drug combines lercanidipine and enalapril, two treatments used for high blood pressure.